Clinical approach to the patient with diabetes mellitus and very high insulin requirements

被引:34
作者
Ovalle, F. [1 ]
机构
[1] Univ Alabama Birmingham, Med Sch Birmingham, Div Endocrinol Diabet & Metab, UAB Comprehens Diabet Ctr, Birmingham, AL 35294 USA
关键词
Diabetes; Insulin; Algorithm; High insulin requirement; Severe insulin resistance; Extreme insulin resistance; ACANTHOSIS NIGRICANS; DOSE INSULIN; LONG-TERM; PLASMA ADIPONECTIN; RECEPTOR GENE; B SYNDROME; RESISTANCE; THERAPY; U-500; HYPERANDROGENISM;
D O I
10.1016/j.diabres.2010.06.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A number of patients with diabetes require very high (>2 U kg(-1) day(-1)), or extremely high (>3 U kg(-1) day(-1)), insulin doses for the management of their hyperglycemia. Unfortunately, many of the physicians who treat these patients limit themselves to prescribing ever higher doses of insulin, without questioning why. Furthermore, when the insulin requirements get to be extreme, demanding an explanation, clinicians are frequently lost in a sea of literature where there is not a single paper dealing with this problem systematically. A systematic approach to the evaluation of these patients is necessary to facilitate an appropriate diagnosis, select the most reasonable therapy, and hopefully improve the long-term outcome of these patients. This manuscript intends to provide the clinician with a review of the literature pertinent for the differential diagnosis, work-up, and management of these patients. We will review the definitions of insulin sensitivity during normality, the various degrees or categories of insulin resistance, and the expected insulin requirements during each of these states. Subsequently, we propose a simple alphabetic mnemonic approach to help remember the differential diagnosis, and a clinical algorithm to help guide the work-up of these patients. Lastly, we briefly discuss general management considerations in these conditions. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:231 / 242
页数:12
相关论文
共 77 条
[1]   Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance) [J].
Arioglu, E ;
Andewelt, A ;
Diabo, C ;
Bell, M ;
Taylor, SI ;
Gorden, P .
MEDICINE, 2002, 81 (02) :87-100
[2]  
AZZIZ R, 1994, FERTIL STERIL, V61, P570
[3]  
BINDER C, 1969, ACTA PHARMACOL TOX, VS 27, P1
[4]   LONG-TERM USE OF INTRAMUSCULAR INSULIN THERAPY IN A TYPE-1 DIABETIC PATIENT WITH SUBCUTANEOUS INSULIN RESISTANCE [J].
BROSSARD, JH ;
HAVRANKOVA, J ;
RIOUX, D ;
BERTRAND, S ;
DAMOUR, P .
DIABETIC MEDICINE, 1993, 10 (02) :174-176
[5]   Lipodystrophy in human immunodeficiency virus-infected patients [J].
Chen, DL ;
Misra, A ;
Garg, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11) :4845-4856
[6]   Efficacy of leptin therapy in the different forms of human lipodystrophy [J].
Chong, A. Y. ;
Lupsa, B. C. ;
Cochran, E. K. ;
Gorden, P. .
DIABETOLOGIA, 2010, 53 (01) :27-35
[7]   The use of U-500 in patients with extreme insulin resistance [J].
Cochran, E ;
Musso, C ;
Gorden, P .
DIABETES CARE, 2005, 28 (05) :1240-1244
[8]   Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome [J].
Cochran, E ;
Young, JR ;
Sebring, N ;
DePaoli, A ;
Oral, EA ;
Gorden, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1548-1554
[9]  
Cochran E., 2009, Diabetes Spectrum, V22, P116, DOI [DOI 10.2337/DIASPECT.22.2116, 10.2337/diaspect.22.2116, DOI 10.2337/DIASPECT.22.2.116]
[10]   Rituximab therapy for the type B syndrome of severe insulin resistance [J].
Coll, AP ;
Thomas, S ;
Mufti, GJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (03) :310-311